A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma

Claudia Campbell, Eric Diamond, William K. Schmidt, Margaret Kelly, Robert Allen, William Houghton, Kerrie L. Brady, James N Campbell

Research output: Contribution to journalArticle

Abstract

Intermetatarsal neuroma or Morton's neuroma is a painful condition of the foot resulting from an entrapment of the common digital nerve typically in the third intermetatarsal space. The pain can be severe and especially problematic with walking. Treatment options are limited and surgery may lead to permanent numbness in the toes. Capsaicin, the pungent ingredient of hot peppers, produces analgesia by inducing retraction of nociceptive afferents from the area of innervation and is effective in treating certain neuropathic pain disorders. A randomized double-blind placebo-controlled study was conducted to test the efficacy, tolerability, and safety of a single 0.1 mg dose of capsaicin vs placebo injected into the region of the neuroma. A total of 58 subjects diagnosed with Morton's neuroma with foot pain ≥4 (0-10 numerical pain rating scale) were injected with 2 mL of lidocaine into the intermetatarsal space proximal to the neuroma to provide local anesthesia. After 5 minutes, 0.1 mg capsaicin or placebo was injected into the intermetatarsal space containing the painful neuroma. Average foot pain was rated for 2 weeks before through 4 weeks after injection. At weeks 1 and 4, the decrease in pain was significantly greater in the subjects treated with capsaicin (P 0.021 and P 0.019, respectively). A trend toward significance was noted at weeks 2 and 3. Improvements in functional interference scores and reductions in oral analgesic use were also seen in the capsaicin-treated group. These findings suggest that injection of capsaicin is an efficacious treatment option for patients with painful intermetatarsal neuroma.

Original languageEnglish (US)
Pages (from-to)1297-1304
Number of pages8
JournalPain
Volume157
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Capsaicin
Placebos
Neuroma
Pain
Foot
Capsicum
Somatoform Disorders
Injections
Hypesthesia
Toes
Neuralgia
Local Anesthesia
Lidocaine
Analgesia
Walking
Analgesics
Morton Neuroma
Safety
Therapeutics

Keywords

  • Capsaicin
  • Clinical trial
  • Intermetatarsal neuroma
  • Morton's neuroma
  • Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology

Cite this

A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma. / Campbell, Claudia; Diamond, Eric; Schmidt, William K.; Kelly, Margaret; Allen, Robert; Houghton, William; Brady, Kerrie L.; Campbell, James N.

In: Pain, Vol. 157, No. 6, 01.06.2016, p. 1297-1304.

Research output: Contribution to journalArticle

Campbell, Claudia ; Diamond, Eric ; Schmidt, William K. ; Kelly, Margaret ; Allen, Robert ; Houghton, William ; Brady, Kerrie L. ; Campbell, James N. / A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma. In: Pain. 2016 ; Vol. 157, No. 6. pp. 1297-1304.
@article{156aa99e75e149f0b77d2147a8c87c0c,
title = "A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma",
abstract = "Intermetatarsal neuroma or Morton's neuroma is a painful condition of the foot resulting from an entrapment of the common digital nerve typically in the third intermetatarsal space. The pain can be severe and especially problematic with walking. Treatment options are limited and surgery may lead to permanent numbness in the toes. Capsaicin, the pungent ingredient of hot peppers, produces analgesia by inducing retraction of nociceptive afferents from the area of innervation and is effective in treating certain neuropathic pain disorders. A randomized double-blind placebo-controlled study was conducted to test the efficacy, tolerability, and safety of a single 0.1 mg dose of capsaicin vs placebo injected into the region of the neuroma. A total of 58 subjects diagnosed with Morton's neuroma with foot pain ≥4 (0-10 numerical pain rating scale) were injected with 2 mL of lidocaine into the intermetatarsal space proximal to the neuroma to provide local anesthesia. After 5 minutes, 0.1 mg capsaicin or placebo was injected into the intermetatarsal space containing the painful neuroma. Average foot pain was rated for 2 weeks before through 4 weeks after injection. At weeks 1 and 4, the decrease in pain was significantly greater in the subjects treated with capsaicin (P 0.021 and P 0.019, respectively). A trend toward significance was noted at weeks 2 and 3. Improvements in functional interference scores and reductions in oral analgesic use were also seen in the capsaicin-treated group. These findings suggest that injection of capsaicin is an efficacious treatment option for patients with painful intermetatarsal neuroma.",
keywords = "Capsaicin, Clinical trial, Intermetatarsal neuroma, Morton's neuroma, Pain",
author = "Claudia Campbell and Eric Diamond and Schmidt, {William K.} and Margaret Kelly and Robert Allen and William Houghton and Brady, {Kerrie L.} and Campbell, {James N}",
year = "2016",
month = "6",
day = "1",
doi = "10.1097/j.pain.0000000000000544",
language = "English (US)",
volume = "157",
pages = "1297--1304",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma

AU - Campbell, Claudia

AU - Diamond, Eric

AU - Schmidt, William K.

AU - Kelly, Margaret

AU - Allen, Robert

AU - Houghton, William

AU - Brady, Kerrie L.

AU - Campbell, James N

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Intermetatarsal neuroma or Morton's neuroma is a painful condition of the foot resulting from an entrapment of the common digital nerve typically in the third intermetatarsal space. The pain can be severe and especially problematic with walking. Treatment options are limited and surgery may lead to permanent numbness in the toes. Capsaicin, the pungent ingredient of hot peppers, produces analgesia by inducing retraction of nociceptive afferents from the area of innervation and is effective in treating certain neuropathic pain disorders. A randomized double-blind placebo-controlled study was conducted to test the efficacy, tolerability, and safety of a single 0.1 mg dose of capsaicin vs placebo injected into the region of the neuroma. A total of 58 subjects diagnosed with Morton's neuroma with foot pain ≥4 (0-10 numerical pain rating scale) were injected with 2 mL of lidocaine into the intermetatarsal space proximal to the neuroma to provide local anesthesia. After 5 minutes, 0.1 mg capsaicin or placebo was injected into the intermetatarsal space containing the painful neuroma. Average foot pain was rated for 2 weeks before through 4 weeks after injection. At weeks 1 and 4, the decrease in pain was significantly greater in the subjects treated with capsaicin (P 0.021 and P 0.019, respectively). A trend toward significance was noted at weeks 2 and 3. Improvements in functional interference scores and reductions in oral analgesic use were also seen in the capsaicin-treated group. These findings suggest that injection of capsaicin is an efficacious treatment option for patients with painful intermetatarsal neuroma.

AB - Intermetatarsal neuroma or Morton's neuroma is a painful condition of the foot resulting from an entrapment of the common digital nerve typically in the third intermetatarsal space. The pain can be severe and especially problematic with walking. Treatment options are limited and surgery may lead to permanent numbness in the toes. Capsaicin, the pungent ingredient of hot peppers, produces analgesia by inducing retraction of nociceptive afferents from the area of innervation and is effective in treating certain neuropathic pain disorders. A randomized double-blind placebo-controlled study was conducted to test the efficacy, tolerability, and safety of a single 0.1 mg dose of capsaicin vs placebo injected into the region of the neuroma. A total of 58 subjects diagnosed with Morton's neuroma with foot pain ≥4 (0-10 numerical pain rating scale) were injected with 2 mL of lidocaine into the intermetatarsal space proximal to the neuroma to provide local anesthesia. After 5 minutes, 0.1 mg capsaicin or placebo was injected into the intermetatarsal space containing the painful neuroma. Average foot pain was rated for 2 weeks before through 4 weeks after injection. At weeks 1 and 4, the decrease in pain was significantly greater in the subjects treated with capsaicin (P 0.021 and P 0.019, respectively). A trend toward significance was noted at weeks 2 and 3. Improvements in functional interference scores and reductions in oral analgesic use were also seen in the capsaicin-treated group. These findings suggest that injection of capsaicin is an efficacious treatment option for patients with painful intermetatarsal neuroma.

KW - Capsaicin

KW - Clinical trial

KW - Intermetatarsal neuroma

KW - Morton's neuroma

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84971331028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971331028&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000000544

DO - 10.1097/j.pain.0000000000000544

M3 - Article

C2 - 26963851

AN - SCOPUS:84971331028

VL - 157

SP - 1297

EP - 1304

JO - Pain

JF - Pain

SN - 0304-3959

IS - 6

ER -